D. RAPSON

1.1k total citations
13 papers, 582 citations indexed

About

D. RAPSON is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, D. RAPSON has authored 13 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 3 papers in Genetics and 3 papers in Genetics. Recurrent topics in D. RAPSON's work include Blood groups and transfusion (8 papers), Platelet Disorders and Treatments (8 papers) and Blood disorders and treatments (3 papers). D. RAPSON is often cited by papers focused on Blood groups and transfusion (8 papers), Platelet Disorders and Treatments (8 papers) and Blood disorders and treatments (3 papers). D. RAPSON collaborates with scholars based in Canada, Netherlands and Bangladesh. D. RAPSON's co-authors include David Lillicrap, Mackenzie Bowman, Wilma M. Hopman, Carol Hegadorn, Julie Grabell, Paula James, Colleen Notley, Christine Hough, Lee A. O’Brien and Angie Tuttle and has published in prestigious journals such as Blood, Journal of Thrombosis and Haemostasis and American Journal of Clinical Pathology.

In The Last Decade

D. RAPSON

13 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. RAPSON Canada 8 501 131 92 86 71 13 582
M. Deforest Canada 6 338 0.7× 72 0.5× 74 0.8× 67 0.8× 50 0.7× 6 408
Stephen Kitchen United Kingdom 5 246 0.5× 38 0.3× 63 0.7× 52 0.6× 31 0.4× 8 304
F. R. Rosendaal Netherlands 9 311 0.6× 39 0.3× 152 1.7× 58 0.7× 26 0.4× 10 447
Marie‐Thérèse Blouch France 7 83 0.2× 30 0.2× 45 0.5× 45 0.5× 142 2.0× 9 380
Jordi Fontcuberta Spain 6 311 0.6× 40 0.3× 100 1.1× 80 0.9× 60 0.8× 7 426
F. A. Scaraggi Italy 11 424 0.8× 23 0.2× 41 0.4× 110 1.3× 22 0.3× 17 505
Sarah L. Janes United Kingdom 6 200 0.4× 56 0.4× 128 1.4× 43 0.5× 10 0.1× 8 385
Jayne L. Bonan United States 6 285 0.6× 105 0.8× 77 0.8× 56 0.7× 26 0.4× 8 443
Juraj Sokol Slovakia 12 202 0.4× 59 0.5× 153 1.7× 46 0.5× 10 0.1× 56 385
Sangeeta Krishnan United States 13 360 0.7× 256 2.0× 29 0.3× 77 0.9× 14 0.2× 32 659

Countries citing papers authored by D. RAPSON

Since Specialization
Citations

This map shows the geographic impact of D. RAPSON's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. RAPSON with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. RAPSON more than expected).

Fields of papers citing papers by D. RAPSON

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. RAPSON. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. RAPSON. The network helps show where D. RAPSON may publish in the future.

Co-authorship network of co-authors of D. RAPSON

This figure shows the co-authorship network connecting the top 25 collaborators of D. RAPSON. A scholar is included among the top collaborators of D. RAPSON based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. RAPSON. D. RAPSON is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bowman, Mackenzie, et al.. (2010). A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population. Pediatric Blood & Cancer. 55(1). 171–173. 40 indexed citations
2.
Bowman, Mackenzie, Julie Grabell, Wilma M. Hopman, et al.. (2008). Generation and validation of the Condensed MCMDM‐1VWD Bleeding Questionnaire for von Willebrand disease. Journal of Thrombosis and Haemostasis. 6(12). 2062–2066. 165 indexed citations
3.
Heyland, Daren K., et al.. (2008). Prevalence, Incidence, and Clinical Resolution of Insulin Resistance in Critically Ill Patients: An Observational Study. Journal of Parenteral and Enteral Nutrition. 32(3). 227–235. 52 indexed citations
4.
James, Paula, Colleen Notley, Carol Hegadorn, et al.. (2007). Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study. Journal of Thrombosis and Haemostasis. 5(9). 1914–1922. 35 indexed citations
5.
Stakiw, Julie, Mackenzie Bowman, Carol Hegadorn, et al.. (2007). The effect of exercise on von Willebrand factor and ADAMTS‐13 in individuals with type 1 and type 2B von Willebrand disease. Journal of Thrombosis and Haemostasis. 6(1). 90–96. 34 indexed citations
6.
RAPSON, D., Mackenzie Bowman, David Lillicrap, & Paula James. (2007). DIAGNOSTIC EFFICACY OF SYSTEMATIC INVESTIGATION OF NON-VON WILLEBRAND BLEEDERS: RESULTS OF A PROSPECTIVE STUDY. Journal of Thrombosis and Haemostasis. 5. P–T. 1 indexed citations
7.
James, Paula D., Colleen Notley, Carol Hegadorn, et al.. (2006). The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood. 109(1). 145–154. 224 indexed citations
8.
Roland, Kaitlyn P., D. RAPSON, David Lillicrap, & Paula James. (2006). The value of genetic testing for type 2B Von Willebrand disease. Clinical & Laboratory Haematology. 28(1). 17–21. 2 indexed citations
9.
Bowman, Mackenzie, Paula James, Marshall Godwin, D. RAPSON, & David Lillicrap. (2005). The Prevalence of von Willebrand Disease in the Primary Care Setting.. Blood. 106(11). 1780–1780. 2 indexed citations
10.
O’Brien, Lee A., Jeffrey J. Sutherland, Carol Hegadorn, et al.. (2004). A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers. Journal of Thrombosis and Haemostasis. 2(7). 1135–1142. 15 indexed citations
11.
RAPSON, D., et al.. (2003). Issues arising in application of the ISTH disseminated intravascular coagulation (DIC) scoring system: the need for modification before prospective validation. Journal of Thrombosis and Haemostasis. 1. P0583–P0583. 1 indexed citations
12.
RAPSON, D., et al.. (2000). Extramedullary Hematopoiesis in a Pyogenic Granuloma. American Journal of Dermatopathology. 22(5). 434–438. 7 indexed citations
13.
Pinkerton, Peter H., et al.. (1984). Sensitivity of Routine Blood Bank Methods for the Detection of Anti-D as Determined during Proficiency Testing. American Journal of Clinical Pathology. 82(3). 326–329. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Deforest Breakdown of academic impact, for papers by Stephen Kitchen Breakdown of academic impact, for papers by F. R. Rosendaal Breakdown of academic impact, for papers by Marie‐Thérèse Blouch Breakdown of academic impact, for papers by Jordi Fontcuberta Breakdown of academic impact, for papers by F. A. Scaraggi Breakdown of academic impact, for papers by Sarah L. Janes Breakdown of academic impact, for papers by Jayne L. Bonan Breakdown of academic impact, for papers by Juraj Sokol Breakdown of academic impact, for papers by Sangeeta Krishnan
Rankless by CCL
2026